Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 806-813

  Johnson, B E ^a   Bridges, J D ^a   Sobczeck, M ^a   Gray, J ^a   Linnoila, R I ^a   Gazdar, A F ^a   Hankins, L ^a   Steinberg, S M ^a   Edison, M ^a   Frame, J N ^a   Pass, H ^a   Nesbitt, J ^a   Holden, D ^a   Mulshine, J L ^a   Glatstein, E ^a   Ihde, D C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 9044228415     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.806     Document Type: Article

References (26)

1. Ihde DC: Drug therapy: Chemotherapy of lung cancer. N Engl J Med 327:1434-1441, 1992
2. Bunn PA, Lichter AS, Makuch RW, et al: Chemotherapy alone or chemotherapy with chest irradiation therapy in limited stage small cell lung cancer. Ann Intern Med 106:655-662, 1987
3. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1628-1624, 1992
4. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895, 1992
5. Natale RB, Shank L, Hilaris B, et al: Combination cyclophosphamide, Adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer. Am J Med 79:303-308, 1985
6. McCracken JD, Janaki LM, Crowley JJ, et al: Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: A Southwest Oncology Group study. J Clin Oncol 8:892-898, 1990
7. Fukuoka M, Furuse K, Saijo N, et al: Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 83:855-861, 1992
8. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336-344, 1993
9. Carney DN, Mitchell JB, Kinsella TJ: In vitro radiation and chemosensitivity of established human small cell lung cancer and its large cell morphologic variants. Cancer Res 43:2806-2811, 1983
10. Turrisi AT III, Glover DJ, Mason BA: A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 15:183-187, 1988
11. Turrisi A, Wagner H, Glover D, et al: Limited small cell lung cancer: Concurrent BID thoracic radiotherapy with platinum-etoposide: An ECOG study. Proc Am Soc Clin Oncol 9:230, 1990 (abstr)
12. Johnson DH, Turrisi AT, Chang AY, et al: Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group. J Clin Oncol 11:879-884, 1993
13. Ihde DC, Mulshine JL, Kramer BS, et al: Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022-2034, 1994
14. Gazdar AF, Steinberg SM, Russell EK, et al: Correlation of in vitro drug-sensitivity testing with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. J Natl Cancer Inst 82:117-124, 1990
15. World Health Organization: The World Health Organization histologic typing of lung tumors: Second edition. Am J Clin Pathol 77:123-136, 1982
16. Kaplan E, Meier P: Non-Parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Turrisi AT III, Glover DJ: Thoracic radiotherapy variables: Influence on local control in small cell lung cancer limited disease. Int J Radiat Oncol Biol Phys 19:1473-1479, 1990
18. Johnson DH, Kim K, Turrisi AT, et al: Cisplatin and etoposide plus concurrent thoracic radiotherapy administered once versus twice daily for limited-stage small cell lung cancer: Preliminary results of an intergroup trial. Proc Am Soc Clin Oncol 13:333, 1994 (abstr)
19. Arriagada R, Le Chevalier T, Borie F, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87:183-190, 1995
20. Hansen HH: Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation. Cancer Chemother Rep 4:239-241, 1973
21. Komaki R, Cox JD, Holoye PY, et al: Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lung. Am J Clin Oncol 6:515-521, 1983
22. Nugent JL, Bunn PA Jr, Matthews MJ, et al: CNS metastases in small cell bronchogenic carcinoma. Cancer 44:1885-1893, 1979
23. Hardisty RM, Norman PM: Meningeal leukaemia. Arch Dis Child 42:441-447, 1967
24. Evans AE, Gilbert ES, Zandstra R: The increasing incidence of central nervous system leukemia in children. Cancer 26:404-409, 1970
25. Bleyer WA: Central nervous system leukemia. Pediatr Clin North America 35:789-814, 1988
26. Hann IM: CNS-directed therapy in childhood acute lymphoblastic leukaemia. Br J Haematol 82:2-5, 1994